Ovid Therapeutics Financial Overview
Ovid Therapeutics's market cap is currently $126.76M. The company's EPS TTM is $-0.17; its P/E ratio is -3.48; Ovid Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.
